版本:
中国

BRIEF-Lannett announces approval for Buprenorphine and Naloxone Sublingual Tablets

Sept 20 Lannett Company Inc :

* Received approval from FDA of ANDA for Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg and 8 mg/2 mg

* Lannett announces approval for Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg and 8 mg/2 mg Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐